SCHEMBL18154161

SCHEMBL18154161

NC(=O)C(N)c1nc2ccc(OC(F)(F)F)cc2s1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.58
RAB9A P51151 2/20 0.58
SCN4A P35499 2/20 0.58
SCN9A Q15858 2/20 0.58
GMNN O75496 1/20 0.58
USP2 O75604 1/20 0.58
LMNA P02545 1/20 0.58
TP53 P04637 1/20 0.58
CYP1A2 P05177 1/20 0.58
CYP3A4 P08684 1/20 0.58
ADORA3 P0DMS8 1/20 0.58
GAA P10253 1/20 0.58
CYP2C9 P11712 1/20 0.58
PKM P14618 1/20 0.58
ALOX15 P16050 1/20 0.58
NFKB1 P19838 1/20 0.58
SLC6A2 P23975 1/20 0.58
BLM P54132 1/20 0.58
PMP22 Q01453 1/20 0.58
SLC6A3 Q01959 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL18190847 0.99 NPC1 (0.59) NPC1RAB9ASCN4ASCN9AGMNN
Hydrochloric Acid SCHEMBL18190932 0.83 DYRK1A (0.57) NPC1RAB9ASCN4ASCN9AGMNN
SCHEMBL13729470 0.81 NPC1 (0.62) NPC1RAB9ASCN4ASCN9AGMNN
SCHEMBL3086757 0.79 NPC1 (0.63) NPC1RAB9ASCN4ASCN9AGMNN
SCHEMBL28588889 0.77 NPC1 (0.60) NPC1RAB9ASCN4ASCN9AGMNN
SCHEMBL21568256 0.76 DYRK1A (0.77) NPC1RAB9ASCN4ASCN9AGMNN
SCHEMBL3635567 0.75 NPC1 (0.61) NPC1RAB9ASCN4ASCN9AGMNN
Riluzole SCHEMBL4443848 0.74 RAB9A (0.82) NPC1RAB9ASCN4ASCN9AGMNN
SCHEMBL20511690 0.74 CYP1A2 (0.56) NPC1RAB9ASCN4ASCN9AGMNN
SCHEMBL16445830 0.74 DYRK1A (0.73) NPC1RAB9ASCN4ASCN9AGMNN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016140878-A9 PRODRUGS RILUZOLE AND THEIR METHOD OF USE BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. (US) 2016-10-20 WO disclosed